Haemonetics Corp. (HAE)
59.43
+0.42
(+0.71%)
USD |
NYSE |
Apr 30, 13:06
Haemonetics EPS Diluted (Quarterly) : 0.9522 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.897 |
| Edwards Lifesciences Corp. | 0.6556 |
| QuidelOrtho Corp. | -1.922 |
| Stryker Corp. | 2.197 |
| Zimmer Biomet Holdings, Inc. | 1.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.74M |
| Revenue (Quarterly) | 338.97M |
| Total Expenses (Quarterly) | 294.23M |
| Enterprise Value | 3.604B |
| Gross Profit Margin (Quarterly) | 56.47% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 6.12% |
| Operating Earnings Yield | 8.51% |
| Normalized Earnings Yield | 6.136 |